Business Development
Mundipharma is committed to improving the health and quality of life of people everywhere.
Mundipharma has its head office in Sydney and State Offices throughout Australia. Our team of medical representatives facilitate the education of General Practitioners, Specialists, Aged Care Facility Nurses and Pharmacists through organising Continuing Medical Educational events.
Our therapeutic areas of interest
We have become world leaders in pain management, developing new medicines and patented formulations to relieve persistent pain and to help patients improve their lives. In addition to our own analgesic pipeline, we continue to look for novel solutions in pain management, and have expanded our therapeutic focus to include:
- Treatments for acute pain, including breakthrough pain
- Treatments for neuropathic pain
- Oncology
- Respiratory medicine
- Central nervous system disorders
- Disorders of inflammation, such as rheumatoid arthritis or gout.
Our Business Development department is actively seeking commercial partnerships for therapeutic drugs in late stage development (marketed, registered or in clinical trials) to complement our product portfolio.
While Mundipharma has the experience to support global business collaborations, we are also happy to discuss opportunities that may be specific for the Asia Pacific region, or limited to the Australian and New Zealand territories.
Mundipharma welcomes discussions regarding business partnerships in a variety of forms, from traditional in-licence agreements and other Sales & Marketing agreements.
Please contact us with any business development enquiries via this e-mail link.